1 |
Nedrow A, Miller J, Walker M, Nygren P, Huffman LH, Nelson HD. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch. Intern. Med. 166: 1453-65 (2006)
DOI
ScienceOn
|
2 |
Hartley DE,Elsabagh S, File SE. Gincosan (a combination of Ginkgobiloba and Panax ginseng): the effects on mood and cognition of 6 and 12 weeks' treatment in post-menopausal women. Nutr. Neurosci. 7: 325-33 (2004)
DOI
ScienceOn
|
3 |
GlazierMG, BowmanMA. A reviewof the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Arch. Intern. Med. 161: 1161-1172 (2001)
DOI
ScienceOn
|
4 |
Warnecke G Influencing menopausal symptoms with a phytotherapeutic agent: successful therapy withcirnicifuga monoextract. Med. Welt. 36: 871-874 (1985)
|
5 |
Stoll W. Phytopharmacon influences atrophic vaginal epithetlium: double-blind study: cimicifuga versus estrogenic substances. Therapeutikon. 1: 23-31 (1987)
|
6 |
E Lehrnann-Willenbrock E, Riedel HH. Clinical and endocrinologic studies of the treatment of ovarian insufficiency manifestations following hysterectomy with intact adnexa. Zentralbl. Gynakol. 110: 611-618 (1988)
ScienceOn
|
7 |
Jacobson JS, Troxel AS, Evans J. Randomized trial of black cohoshfor the treatment of hot flashes amongwomenwith a history of breastcancer. J. Clin. Oncol. 19:2739-2745 (2001)
DOI
ScienceOn
|
8 |
FarhatMY, LavigneMC, Ramwell PW. The vascularprotective effects of estrogen. FASEB. J. 10: 615-624 (1996)
DOI
ScienceOn
|
9 |
Kim HS, Zhang YR, Fang LH, Lee MK. Effects of ginsenosides on bovine adrenal tyrosine hydroxylase. J. Ethnopharmacal. 66: 107-111 (1999)
DOI
ScienceOn
|
10 |
Ivanova T, Beyer C. Estrogen regulates tyrosine hydroxylase expression in the neonate mouse midbrain. J. Neurobiol. 54, 638-647 (2003)
DOI
ScienceOn
|
11 |
MishraSI, Dickerson V, Najm W. Phytoestrogens and breast cancer prevention: what is the evidence? Am J. Obstet. Gynecol. 188: 66-70 (2003)
DOI
ScienceOn
|
12 |
Yoon M, Lee H, Jeong S, Kim J.J., Nicol CJ. Nam KW, Kim M, Cho Bo, Oh Gr. Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng. Brl. Pharmacol. 138: 1295-1302 (2003)
DOI
ScienceOn
|
13 |
Park KH, Shin HJ, Song YB, Hyun HC, Cho HJ, Ham HS, YooYB, Ko YC, Jun WT, Park HJ. Possible role of ginsenoside RbI on regulation of rat liver triglycerides. Biol. Pharm. Bull. 25: 457-460 (2002)
DOI
ScienceOn
|
14 |
Nemmani KV, Ramarao P. Ginsenoside Rf potentiates U50,488H-induced analgesia and inhibits tolerance to its analgesia in mice. Life Sci. 72: 759-768 (2003)
DOI
ScienceOn
|
15 |
Scott GI, Colligan PB, Ren BH, Ren J. Ginsenosides and Re decrease cardiac contraction in adult rat ventricular myocytes: role of nitric oxide. Br J Pharmacol. 134: 1159-1165 (2001)
DOI
ScienceOn
|
16 |
Amato P, Christophe S, Mellon PL. Estrogenic activity of herbs commonly used as remedies for menopausal symptoms. Menopause. 9: 145-150(2002)
DOI
ScienceOn
|
17 |
Chen X. Cardiovascular protection by ginsenosides and their nitric oxide releasing action. Clin Exp Pharmacol. Physiol. 23: 728-732 (1996)
DOI
ScienceOn
|
18 |
Ernst E, Cassileth BR.How usefulare unconventional cancer treatments? Eur J. Cancer. 35: 1608-1613 (1999)
DOI
ScienceOn
|
19 |
Choi S, Jung SY, Ko YS, Koh SR, Rhim H, Nah sv Functional expression of a novel ginsenoside Rf binding protein from rat brainmRNAin Xenopus laevis oocytes. Mol. Pharmacal. 61: 928-935 (2002)
DOI
ScienceOn
|
20 |
Kronenberg F, Fugh-Berman A. Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann. Intern. Med. 137: 805-813 (2002)
DOI
ScienceOn
|
21 |
Hoffman GE, Zup SP. Good versus evil: changing the approach to hormone replacement therapy. Endocrinology. 144: 468-4699 (2003)
|
22 |
Turgeon JL, McDonnell DP, Martin KA, Wise PM. Hormone therapy: physiological complexity belies therapeutic simplicity. Science. 304: 1269-1273 (2004)
DOI
ScienceOn
|
23 |
Woo J, Lau E, Ho SC, Cheng F, Chan C, Chan AS, Haines CJ, Chan TY, Li M, Sham A. Comparison of Puerarialobata with hormone replacement therapy in treating the adverse health consequences of menopause. Menopause. 10: 352-361 (2003)
DOI
ScienceOn
|
24 |
Cassidy A. Potential risks and benefits of phytoestrogen-rich diets. Int J .Vitam. Nutr. Res. 73: 120-126 (2003)
DOI
ScienceOn
|
25 |
Writing group for the women's health initiative investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA. 288: 321-333 (2002)
DOI
ScienceOn
|
26 |
Lee YJ, Gorski J. Estrogen-induced transcription of the progesterone receptor gene does not parallel estrogen receptor occupancy. Proc Natl Acad Sci USA. 93: 15180-15184 (1996)
DOI
ScienceOn
|
27 |
Cos P, De Bruyne T, Apers S, Vanden Berghe D, Pieters L, Vlietinck AJ. Phytoestrogens: recent developments. Planta. Med. 69: 589-599 (2003)
DOI
ScienceOn
|
28 |
Joo HK, Lee SK, Kim HS, Song YJ, Kang O, Park JB, Lee KH, Cho EJ, Lee JR, Seong IW, Kim SH, Cho CH, Jeon BH. Korean red ginseng extract inhibits tumor necrosis factor-alpha-induced monocyte adhesion in the humanendothelial cells. J Ginseng Res. 3: 244-249 (2008)
|
29 |
Saiki Ikuo. In vivo anti-metastatic action of Ginseng Saponins is based on their intestinal bacterial metabolites after oral administration. J Ginseng Res. 1: 1-13 (2007)
과학기술학회마을
|
30 |
Lee JH, Choi SH, Nah sv Studyon life span extension efficacy by korean red ginseng. J Ginseng Res. 4: 210-216 (2007)
|
31 |
Attele AS, Wu JA, Yuan CS. Ginseng Pharmacology: Multiple constituents and multiple actions. Biochem. Pharmacol. 58: 1685-1693 (1999)
DOI
ScienceOn
|
32 |
Yuan CS, Wu JA. Ginsenoside variability in American ginseng samples. Am J. Clin. Nut. 75: 600-601 (2002)
DOI
|
33 |
Xing YZ, ShangHC, Gao XM, Zhang BL. A comparison of the ancient use of ginseng in traditional Chinese medicine with modem pharmacological experiment and clinical trials. Phytother Res. 22: 851-858 (2008)
DOI
ScienceOn
|
34 |
Wiklund IK, Mattsson LA, Lindgren R, Limoni C. Effects of a standardized ginseng extracton quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Swedish Alternative Medicine Group.: Int J. Clin. Pharmacol. Res. 19: 89-99 (1999)
ScienceOn
|
35 |
Viereck V, Emons G, Wuttke W. Black cohosh: just another phytoestrogen? Trends. Endocrinol. Metab. 16: 214-221 (2005)
DOI
ScienceOn
|
36 |
Davis VL,Jayo MJ, Ho A, Kotlarczyk MP, HardyM.L, Foster WG, Hughes CL. Black cohosh increases metastatic mammary cancer in transgenic mice expressing c-erbB2. Cancer. Res. 68: 8377-83 (2008)
DOI
ScienceOn
|
37 |
Wong VC, Lim CE, Luo X, Wong WS. Current alternative and complementary therapies used in menopause. : Gynecol. Endocrinol. 25: 166-74 (2009)
DOI
ScienceOn
|
38 |
Tode T, Kikuchi Y, Hirata J, Kita T, Nakata H, Nagata I. Effect of Korean red ginseng on psychological functions in patients with severeclimacteric syndromes. Int J. Gynaecol. Obstet. 67: 169-74 (1999)
DOI
ScienceOn
|
39 |
Liske E, Hanggi W, Henneicke-von ZepelinHH, Boblitz N, Wustenberg P, Rahlfs VW. Physiological investigation of a uniqueextract of black cohosh (Cimicifugae racemosae rhizoma): a six-month clinical study demonstrates no systemic estrogenic effect. J. Womens Health Gend Based. Med. 11: 163-174 (2002)
DOI
ScienceOn
|
40 |
Liske E, Wtistenberg P. Therapy of climacteric complaints with Cimicfuga racemosa: a herbal medicine with clinically provenevidence. Poster Presentation. North American Menopause Society (1998)
|
41 |
Wuttke W, Seidlova-Wuttke D, Gorkow C. The Cimicifuga preparation BNO 1055 versusconjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas. 44: S67-S77 (2003)
DOI
ScienceOn
|
42 |
Duda RB, Zhong YZ, Navas V, Li MZC, Toy BR. Alavarez JG. American ginseng and breast cancer therapeutic agents synergistically inhibit MCF-7 breast cancer cell growth. J. Surg. Oncol. 72: 230-239 (1999)
DOI
ScienceOn
|
43 |
Chan RY, Chen WF, Dong A, Guo D, Wong MS. Estrogenlikeactivity of ginsenoside Rgl derived from Panax notoginseng. J. Clin. Endocrinol. Metab. 87: 3691-3695 (2002)
DOI
ScienceOn
|
44 |
Lau WS, Chen WF, Chan RY, Guo DA, Wong MS. Mitoenactivated protein kinase (MAPK) pathway mediates the oestrogen-like activities of ginsenoside Rgl in human breast cancer(MCF-7) cells. Brl. Pharmacol. 156: 1136-1146 (2009)
DOI
ScienceOn
|
45 |
Lee Y, Jin Y,Lim W, Ji S, Choi S, Jang S, Lee S. A ginsenoside-Rhl, a component of ginseng saponin, activates estrogen receptor in human breast carcinoma MCF-7 cells. J. Steroid. Biochem. Mol. Biol, 84: 463-468 (2003)
DOI
ScienceOn
|